A review on newly approved PARP inhibitors: Talazoparib and Olaparib

অনুরূপ উপাদানগুলি

• A review on potential of PARP inhibitors in the treatment of prostate cancer
  অনুযায়ী: Islam, Saidul
  প্রকাশিত: (2022)
• Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
  অনুযায়ী: Ahmed, Nafisa
  প্রকাশিত: (2023)
• SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
  অনুযায়ী: Meem, Manila
  প্রকাশিত: (2023)
• Mutation in DNA polymerase γ: mitochondrial disorders
  অনুযায়ী: Hossain, Sadman Sanjid
  প্রকাশিত: (2023)
• RIPK pathway, as a potential target, for cancer treatment - a review
  অনুযায়ী: Jahan, Nusrat
  প্রকাশিত: (2024)